PURA - Puration To Review Q3 100 Percent Revenue Growth And 2019 $4 Million Revenue Target In Management Update Tomorrow
November 25 2019 - 11:37AM
InvestorsHub NewsWire
PURA - Puration To Review Q3 100
Percent Revenue Growth And 2019 $4 Million Revenue Target In
Management Update Tomorrow
Dallas, TX -- November 25, 2019 -- InvestorsHub
NewsWire -- Puration, Inc. (USOTC:
PURA) today confirmed a scheduled management update to be
published tomorrow on Tuesday, November 26, 2019 to review the
recent financial reported filed with OTC Markets for the period
ended September 30, 2019. The update will include the latest
on management’s $4 million 2019 revenue target and plans for
reaching $8 million in 2020. PURA reported over one hundred
percent (100%) revenue growth year-to-date through the period ended
September 30, 2019 compared to the same period in the previous
year, 2018. PURA reported $1,895,000 in revenue for the
period ending September 30, 2019 and a twelve percent (12%) net
profit at $232,500. The company has recently announced major
new distribution agreements with initial orders commencing in the
fourth quarter of 2019 and management maintains its $4 million 2019
revenue target.
For
more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This
news release contains forward-looking statements within the meaning
of the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024